2022.03.18

News

[Patient’s Voice] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Disease (March 18, 2022)

2022.03.17

Event

[Activity Report] Submission of recommendations to Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)” (March 17, 2022)

2022.03.07

News

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Monitoring Linezolid Blood Levels – Enabling Long-Term Linezolid Use for the Successful Treatment of Refractory Pyogenic Spondylodiscitis” (March 7, 2022)

2022.02.22

News

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)

2022.01.14

News

[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Personal Opinion and Insight, December 20, 2021)

2021.12.27

Event

[Event Report] The Third Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 17, 2021)

2021.12.23

Event

[Event Report] FY2022 AMR Alliance Japan Planning Meeting (December 6, 2021)

2021.12.22

News

[Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (December 22, 2021)

2021.12.02

News

[Publication Report] Incentivizing Resilience: Accelerating Efforts to Promote the Research and Development Needed to Save the World from the Next Pandemic (December 2, 2021)

2021.12.02

Event

[Event Report] Investing in the Future: The Role of Investors in Saving the World from AMR (September 8, 2021)

2021.11.26

News

[Research Report] Nearly 60% Would Pay More for New Antibiotics – Although knowledge of the threat of AMR remains low, new HGPI poll suggests that Japanese public would be willing to consider further financial support for new antibiotics (November 26, 2021)

2021.11.26

News

[Publication Report] Taking Action for AMR Preparedness: Spurring Antibiotic Innovation for Healthy Ageing in Super-Ageing Japan (November 18, 2021)

2021.11.18

News

[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (November 18, 2021)

2021.11.17

News

[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan – Following the 72nd Session of the World Health Organization Regional Committee for the Western Pacific, held in Himeji City, the City Government announced its participation in AMR Alliance Japan (November 17, 2021)

2021.11.10

Event

[Event Report] The 8th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 28, 2021)

2021.11.09

Event

[Registration Closed] (Webinar) The 101st HGPI Seminar “Looking Back at the History of Infectious Diseases to Think About the Future of AMR Countermeasures – A Seminar in Commemoration of AMR Awareness Month” (November 24, 2021)

2021.10.18

News

[Policy Recommendations] “Setting Appropriate Outcome Indices in the Next AMR Action Plan” (October 18, 2021)

2021.10.13

News

[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance (October 12, 2021)

2021.10.12

News

[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria” (October 12, 2021)

2021.09.29

News

[In the Media] ”Discussion around AMR（Antimicrobial Resistance）at International Symposium at Himeji – One Month to Go Before WHO Regional Committee for the Western Pacific ”（Kobe Shimbun, September 26, 2021）